Skip to main content
. 2026 Sep 16;16:1891664. doi: 10.3389/fcimb.2026.1891664

Table 1.

Baseline characteristics of critically ill patients with urosepsis stratified by tertiles of logLDAR.

Characteristics All patients (N = 3060) Low tertile (N = 1020) Moderate tertile (N = 1020) High tertile (N = 1020) P value
LDAR 171 (317) 62.4 (12.5) 102 (13.8) 348 (503) 0.000
logLDAR 6.84 (1.03) 5.93 (0.32) 6.66 (0.19) 7.93 (0.98) 0.000
Age 70.5 (15.1) 71.0 (14.7) 71.6 (14.9) 69.0 (15.5) <0.001
Gender: 1329 (43.4%) 445 (43.6%) 454 (44.5%) 430 (42.2%) 0.556
Race: 1981 (64.7%) 683 (67.0%) 676 (66.3%) 622 (61.0%) 0.008
Weight 82.0 (26.0) 82.1 (25.6) 80.7 (25.2) 83.3 (27.1) 0.076
HPY: 1077 (35.2%) 387 (37.9%) 349 (34.2%) 341 (33.4%) 0.075
AKI: 1918 (62.7%) 563 (55.2%) 636 (62.4%) 719 (70.5%) <0.001
CKD: 889 (29.1%) 299 (29.3%) 306 (30.0%) 284 (27.8%) 0.548
DM: 1155 (37.7%) 387 (37.9%) 399 (39.1%) 369 (36.2%) 0.386
HLD: 1074 (35.1%) 376 (36.9%) 363 (35.6%) 335 (32.8%) 0.151
HF: 1201 (39.2%) 371 (36.4%) 428 (42.0%) 402 (39.4%) 0.035
MI: 316 (10.3%) 55 (5.39%) 110 (10.8%) 151 (14.8%) <0.001
IHD: 1126 (36.8%) 326 (32.0%) 392 (38.4%) 408 (40.0%) <0.001
COPD: 492 (16.1%) 189 (18.5%) 156 (15.3%) 147 (14.4%) 0.029
SOFA 6.90 (3.46) 6.06 (3.12) 6.71 (3.24) 7.92 (3.72) <0.001
APSIII 58.9 (21.1) 54.1 (18.7) 57.7 (19.8) 65.0 (23.0) <0.001
SAPSII 45.0 (13.4) 42.5 (12.3) 44.5 (12.7) 48.2 (14.5) <0.001
OASIS 36.0 (8.33) 34.7 (7.94) 36.0 (7.96) 37.2 (8.88) <0.001
Charlson 6.31 (2.91) 6.19 (2.87) 6.43 (2.82) 6.31 (3.03) 0.165
APACHEII 21.8 (7.00) 20.5 (6.42) 21.7 (6.85) 23.2 (7.44) <0.001
HR 91.5 (21.3) 88.0 (20.4) 91.4 (20.6) 94.9 (22.2) <0.001
NBPS 120 (25.8) 123 (25.3) 120 (25.6) 118 (26.2) <0.001
NBPD 67.6 (19.8) 67.2 (19.3) 67.6 (19.8) 67.8 (20.3) 0.788
RR 20.2 (6.39) 19.6 (6.11) 20.5 (6.71) 20.5 (6.31) 0.002
Spo2 96.5 (4.68) 96.8 (4.25) 96.6 (4.14) 96.1 (5.51) 0.004
HCT 31.3 (6.64) 31.4 (6.39) 31.5 (6.69) 31.1 (6.84) 0.392
Hb 10.1 (2.20) 10.1 (2.14) 10.2 (2.22) 10.1 (2.24) 0.457
PLT 200 (117) 205 (108) 207 (119) 189 (123) 0.001
RDW 16.1 (2.61) 15.8 (2.39) 16.0 (2.54) 16.4 (2.86) <0.001
RBC 3.40 (0.78) 3.42 (0.76) 3.41 (0.77) 3.37 (0.80) 0.242
WBC 13.9 (14.8) 12.2 (17.0) 13.7 (10.3) 15.7 (15.9) <0.001
ALB 2.90 (0.62) 3.20 (0.55) 2.86 (0.57) 2.65 (0.60) <0.001
GP 15.7 (4.76) 15.2 (4.34) 15.4 (4.55) 16.6 (5.23) <0.001
Ca 8.26 (0.98) 8.47 (0.94) 8.24 (0.89) 8.07 (1.07) <0.001
Cl 104 (8.02) 104 (7.64) 104 (8.03) 104 (8.38) 0.233
Glu 133 (105,175) 130 [102;166] 133 [106;175] 137 [106;187] 0.004
K 4.23 (0.81) 4.20 (0.74) 4.15 (0.78) 4.33 (0.88) <0.001
Na 139 (6.86) 138 (6.41) 139 (6.96) 138 (7.16) 0.015
CO2CP 23.9 (6.55) 24.6 (6.86) 24.3 (6.36) 22.7 (6.24) <0.001
LAC 2.40 (1.99) 1.89 (1.40) 2.26 (1.67) 3.04 (2.53) <0.001
PCO2 42.2 (12.7) 43.1 (13.8) 42.2 (12.3) 41.2 (11.9) 0.004
PH 7.35 (0.11) 7.35 (0.10) 7.36 (0.10) 7.33 (0.11) <0.001
PO2 116 (95.3) 115 (93.7) 115 (94.1) 118 (98.3) 0.705
INR 1.40 [1.20;1.70] 1.30 [1.10;1.70] 1.40 [1.20;1.70] 1.50 [1.20;1.90] <0.001
PT 15.0 [13.0;18.9] 14.4 [12.6;18.0] 14.9 [12.9;18.4] 15.9 [13.5;20.3] <0.001
PTT 32.4 [27.8;41.2] 31.1 [27.4;39.3] 32.2 [27.5;40.8] 33.9 [28.6;44.2] <0.001
ALT 25.0 [15.0;53.0] 18.0 [12.0;28.2] 25.0 [15.0;47.0] 44.0 [22.8;130] <0.001
AST 39.0 [23.0;86.0] 25.0 [18.0;39.2] 37.0 [23.0;68.0] 86.0 [42.0;258] <0.001
TB 0.70 [0.40;1.40] 0.50 [0.30;1.10] 0.60 [0.40;1.40] 0.90 [0.50;2.10] <0.001
CREA 1.30 [0.80;2.20] 1.20 [0.80;2.10] 1.30 [0.80;2.10] 1.40 [0.90;2.40] <0.001
UREA 29.0 [18.0;49.0] 27.0 [17.0;46.0] 28.0 [17.0;49.0] 32.0 [19.0;54.0] <0.001
LDH 284 [214;409] 198 [165;227] 286 [242;333] 510 [399;799] 0.000
SA: 2052 (67.1%) 610 (59.8%) 689 (67.5%) 753 (73.8%) <0.001
VP: 1908 (62.4%) 522 (51.2%) 660 (64.7%) 726 (71.2%) <0.001
GC: 995 (32.5%) 293 (28.7%) 340 (33.3%) 362 (35.5%) 0.004
Ventilation: 2637 (86.2%) 856 (83.9%) 893 (87.5%) 888 (87.1%) 0.036
CRRT: 321 (10.5%) 71 (6.96%) 81 (7.94%) 169 (16.6%) <0.001
Hosp day 13.2 [7.59;23.2] 12.2 [6.91;21.7] 13.5 [7.80;22.8] 14.2 [7.91;24.8] 0.002
ICU day 3.97 [1.98;8.79] 3.44 [1.82;7.59] 4.04 [1.95;8.23] 4.67 [2.32;10.2] <0.001
Hosp dead 437 (14.3%) 84 (8.24%) 128 (12.5%) 225 (22.1%) <0.001
ICU dead 471 (15.4%) 92 (9.02%) 140 (13.7%) 239 (23.4%) <0.001

Data are presented as mean (SD), median [IQR], or n (%). P-values were calculated using ANOVA, Kruskal-Wallis test, chi-squared test, or Fisher’s exact test as appropriate. AKI, acute kidney injury; ALB, albumin; ALT, alanine aminotransferase; APACHE II, Acute Physiology and Chronic Health Evaluation II; APS III, Acute Physiology Score III; AST, aspartate aminotransferase; Ca, calcium; CI, confidence interval; CKD, chronic kidney disease; Cl, chloride; COPD, chronic obstructive pulmonary disease; CO2CP, total carbon dioxide combining power; CREA, creatinine; CRRT, continuous renal replacement therapy; DM, diabetes mellitus; GA, gap of anion; GC, glucocorticoid; Glu, glucose; Hb, hemoglobin; HCT, hematocrit; HF, heart failure; HLD, hyperlipidemia; HPY, hypertension; HR, heart rate; ICU, intensive care unit; IHD, ischemic heart disease; INR, international normalized ratio; K, potassium; LAC, lactate; LDH, lactate dehydrogenase; MI, myocardial infarction; Na, sodium; NBPD, non-invasive blood pressure diastolic; NBPS, non-invasive blood pressure systolic; OASIS, Oxford Acute Severity of Illness Score; PCO2, partial pressure of carbon dioxide; PH, potential of hydrogen; PLT, platelet count; PO2, partial pressure of oxygen; PT, prothrombin time; PTT, partial thromboplastin time; RBC, red blood cell count; RDW, red cell distribution width; RR, respiratory rate; SA, sedation-analgesia; SAPS II, Simplified Acute Physiology Score II; SOFA, Sequential Organ Failure Assessment; SpO2, oxygen saturation; TB, total bilirubin; UREA, urea; VP, vasopressor; WBC, white blood cell count.